Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

61.12
+0.27000.44%
Volume:263.50K
Turnover:15.96M
Market Cap:5.93B
PE:26.14
High:61.14
Open:59.98
Low:59.62
Close:60.85
Loading ...

Why Sarepta Therapeutics, Inc. (SRPT) is Among the Best Oversold NASDAQ Stocks to Buy Right Now

Insider Monkey
·
15 hours ago

Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
Yesterday

Press Release: Sarepta Therapeutics to Announce First Quarter 2025 Financial Results

Dow Jones
·
22 Apr

BRIEF-Sarepta Therapeutics To Announce First Quarter 2025 Financial Results

Reuters
·
22 Apr

Sarepta Therapeutics to Announce First Quarter 2025 Financial Results

THOMSON REUTERS
·
22 Apr

Sarepta Therapeutics Inc : Leerink Partners Cuts Target Price to $150 From $200

THOMSON REUTERS
·
22 Apr

Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
21 Apr

Sarepta price target lowered to $110 from $182 at Piper Sandler

TIPRANKS
·
21 Apr

U.S. RESEARCH ROUNDUP-Lowe's, Netflix, Vulcan Materials

Reuters
·
21 Apr

Sarepta Therapeutics Inc : Piper Sandler Cuts Target Price to $110 From $182

THOMSON REUTERS
·
21 Apr

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
19 Apr

BofA Adjusts Price Target on Sarepta Therapeutics to $157 From $179, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Sarepta Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Apr

SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies

Zacks
·
16 Apr

Cautious Hold Rating on Sarepta Therapeutics Amid Limited LGMD Market and ELEVIDYS Uncertainties

TIPRANKS
·
16 Apr

Sarepta Therapeutics Inc: U.S. FDA Has Confirmed That Screening and Dosing May Proceed in Study Srp-9005-101 for Lgmd2c/R5

THOMSON REUTERS
·
15 Apr

Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs

THOMSON REUTERS
·
15 Apr

Sarepta Therapeutics Inc: Data Expected for Srp-9003 for Lgmd2e/R4 by Mid-2025

THOMSON REUTERS
·
15 Apr

Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs

Business Wire
·
15 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Wells Fargo, American Express, Mondelez

Reuters
·
12 Apr